Hospital/Clinical Laboratories to Dominate Infectious Disease Testing Market until 2025
Increasing global prevalence
of infectious diseases and technological advancements to drive the growth of
global infectious disease testing market
According
to TechSci Research report, “Global
Infectious
Disease Testing Market By Product & Service
(Assays, Kits, & Reagents; Instruments; Services & Software), By Technology
(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Others), By
Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular fever,
Coronavirus, Others), By End User (Hospital/Clinical Laboratories, Reference
Laboratories, Physician Offices, Academic/Research Institutes, Other), By
Region, Forecast & Opportunities, 2025”, global
infectious disease testing market is expected to witness a CAGR during the
forecast period. Rising old aged population is one of the major factors accounting for the growth
of global infectious disease testing market. Moreover, increase in funding for
research on infectious disease diagnostics is expected to bode well for the
growth of global infectious disease testing market through 2025. In addition to
this, rapid shift from centralized laboratories to decentralized point-of-care
testing, is positively influencing the growth of global infectious disease
testing market in the years to come. Also, surging requirement for rapid
diagnostic technique over current techniques due to long turnaround time are
making headway for the growth of global infectious disease testing market.
Along with this, supportive government funding is positively contributing to
the market growth. However, there are some factors that might act as major
impediments to the growth of global infectious disease testing market through
2025 such as rising healthcare costs and reimbursement concerns.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" Global Infectious Disease
Testing Market "
https://www.techsciresearch.com/report/infectious-disease-testing-market/4695.html
Global
infectious disease testing market can be segmented based on product and
service, technology, disease, end user, company, and region. Considering the
disease, the market is fragmented into hepatitis, HIV, HAIS, HPV, TB, influenza,
glandular fever, coronavirus and others. The hospital acquired infections (HAI)
segment dominated the global infectious disease testing market in terms of
largest market share until 2019 and is further anticipated to hold its
dominance during the forecast years as well which can be accredited to the rising
burden of MRSA infections coupled with increasing number of new products that
are continuously being launched in the market. Moreover, upsurge in the
adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff
assay, Xpert MRSA NxG, and ARIES C is anticipated to boost the growth of
segment. In terms of end user, the market is fragmented into hospital/clinical
laboratories, reference laboratories, physician offices, academic/research
institutes, and others. Out of which, the hospital/clinical laboratories segment
is anticipated to grow at a rapid pace during the forecast years on account of
fact that hospital laboratories are more accessible when compared to reference
laboratories and offer test results quickly. Furthermore, increase in medicare reimbursement
for clinical tests which are being done in hospitals is another key factor
augmenting the demand of the segment over the years to come.
Abbott Laboratories, Becton, Dickinson
and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation,
Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG,
Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann-La Roche Ltd,
Cepheid, are among others are the leading players operating in
global infectious disease testing market. The market
players are adopting several growth strategies to enhance infectious disease
testing market. Other competitive strategies include product launches; mergers
& acquisitions; agreements, partnerships, and collaborations; and
expansions to diverse their product portfolio in order to strengthen their
market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4695
customers can also request for 10% free customization on
this report.
“North America is
forecast to dominate the global infectious disease testing market during the
next five years on account of presence of an advanced healthcare facility in
the region. Furthermore, growing investments in the healthcare sector is also
contributing to the growing trend. Additionally, existence of several leading
national clinical laboratories is expected to further boost the market growth
in region over the coming years.”, said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Global Infectious Disease Testing Market By Product
& Service (Assays, Kits, & Reagents; Instruments; Services &
Software), By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase
Chain Reaction, Others), By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza,
Glandular fever, Coronavirus, Others), By End User (Hospital/Clinical
Laboratories, Reference Laboratories, Physician Offices, Academic/Research
Institutes, Other), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global infectious
disease testing market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in global infectious
disease testing market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]